Panzyga (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Panzyga, is an immunoglobulin presented as a unknown/Intravenous solution for intravenous use. It replaces deficient antibodies and is used in primary immunodeficiency disorders and certain immune‑mediated conditions in both children and adults.

GNH USA supplies Panzyga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Panzyga is an immunoglobulin therapy that acts on the immune system to provide passive immunity in several clinical settings. - Primary immunodeficiency diseases (PIDD): Improves the ability to gain the patient to fight against the infection by supplying antibody replacements. - Secondary of immune disorders such as K‑ K   . -  . - . - .

Common